Introduction: Acute coronary syndrome in people under the age of 35 is a distinct subset of the population with a different clinical presentation than older individuals. The pattern and intensity of coronary artery involvement vary, indicating a varied underlying etiology. Improved management will result from a better grasp of this unique challenge. The aim of the study was to understand the common factors and features affecting patients with ACS. Methods: This cross-sectional observational study was conducted at the department of cardiology, Prime Medical College Hospital, Rangpur, Bangladesh during the period of January 2019 to December 2020. A total of 40 participants were selected through purposive sampling technique following the inclusion and exclusion criteria. Result: Male: Female ratio was 9:1, and majority (67.5%) were from the age group of 31-35 years. Obesity was observed in 12.5% of the participants, while 27.5% were overweight. 22.5% of the participants had mild stress, while the remaining 15% of the participants had moderate levels of stress. Chest pain was a common presentation among all the participants, and 30% had shortness of breath. Conclusion: The Acute coronary syndrome in young is almost exclusively seen in male. Smoking, family history of coronary artery disease, dyslipidemia, raised LpA are major risk factors.
Introduction: Women's cardiovascular risk is not adequately addressed, particularly during the menopausal transition when the risk of cardiovascular events rises. Women die from cardiovascular disease (CVD) more frequently than any other cause. The study's objective was to evaluate pre-menopausal women's heart disease risk in connection to oral contraceptive tablets. Method: A comparative observational study was conducted at the department of cardiology, Prime Medical College Hospital, Rangpur, Bangladesh during the period of January 2020 to December 2020. A total of 140 participants were included for the study. Among them 70 women with HD (Heart Disease) were Group I and 70 women without HD (Heart Disease) were Group II. Respectively women were assessed exclusively using a case sheet that include age, full medical history, past medical history (mainly hypertension), family history, smoking history & the use of oral contraceptive pill (OCP) and duration of use. Statistical analyses were done by using SPSS 19.0 for windows Inc. Results: Mean age was 45.97 ±0.46 women with HD and 44.83 ±0.57 was women without HD. Women with HD age range 50-55 were 82.9 % (58) and 81.4% (57) were women without HD. Overweight & Obese were 66(94.3%) women with HD and 50(71.4%) were women without HD. Dyslipidemia were 69(98.6%) women with HD and 16(22.9%) were women without HD. Hypertension 65(92.8%)were women with HD and 16(22.9%) were women without HD. Use of OCP was higher among women with HD 61(87.1%) as compared with those without HD 29(41.4%). Duration of OCP was significantly longer in women with HD than women without HD. The effect of OCP use in women with Hypertension 40(61.33%) were women with HD and 6 (37.50%)were women without HD. The effect of OCP use in women with Smoking 10 (68.42%)were women with HD and 1 (25%)were women without HD. The effect of OCP use in women with Family history 34 (57.14%)were women with HD and 6 (33.33%)were women without HD. This study has confirmed the aforesaid findings in which the use of OCP increase the risk of HD in premenopausal women specifically in those who already have risk factors of HD. The effect of OCP use in women with Hypertension 51(61.5%) were women with HD and 6 (35.8%) were women without HD. Conclusion: The risk of heart disease was increased among women who used oral contraceptives. Cardiovascular events can be abridged by the management of risk factors. Mainly significant is the control of hypertension, lipids, and other factors contributing to the metabolic syndrome.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.